Amitriptyline hydrochloride and Retinal detachment - a phase IV clinical study of FDA data

Summary:

Retinal detachment is reported as a side effect among people who take Amitriptyline hydrochloride (amitriptyline hydrochloride), especially for people who are female, 50-59 old, also take Glatiramer Acetate, and have Bleeding disorders.

The phase IV clinical study analyzes which people have Retinal detachment when taking Amitriptyline hydrochloride. It is created by eHealthMe based on reports of 16,582 people who have side effects when taking Amitriptyline hydrochloride from the FDA, and is updated regularly.

What is Amitriptyline hydrochloride?

Amitriptyline hydrochloride has active ingredients of amitriptyline hydrochloride. It is often used in migraine. eHealthMe is studying from 20,054 Amitriptyline hydrochloride users. Check the latest studies of Amitriptyline hydrochloride.

What is Retinal detachment?

Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue) is found to be associated with 714 drugs and 1,007 conditions by eHealthMe. Check the latest studies of Retinal detachment.

On Jul, 21, 2026

16,582 people reported to have side effects when taking Amitriptyline hydrochloride.
Among them, 13 people (0.08%) have Retinal detachment.

Could Amitriptyline hydrochloride cause Retinal detachment?

Among these 13 people:

What is the gender of people who have Retinal detachment when taking Amitriptyline hydrochloride? *

female: 100 %
male: 0.0 %

What is the age of people who have Retinal detachment when taking Amitriptyline hydrochloride? *

What are other drugs people take besides Amitriptyline hydrochloride? *

What are other side effects people have besides Retinal detachment? *

Vitreous Haemorrhage (intraocular (inside the eye) bleeding): 8 people, 61.54%
Visual Impairment: 1 person, 7.69%
Blindness Unilateral: 1 person, 7.69%

What are the existing conditions these people have? *

Type 1 Diabetes: 1 person, 7.69%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 1 person, 7.69%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
High Blood Cholesterol: 1 person, 7.69%
Gait Disturbance: 1 person, 7.69%
Diabetes: 1 person, 7.69%
Bleeding Disorders: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Amitriptyline hydrochloride and have Retinal detachment?

- Check whether Retinal detachment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amitriptyline hydrochloride:

Amitriptyline hydrochloride (20,054 reports)

Browse all side effects of Amitriptyline hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal detachment:

Retinal detachment (714 drugs)

Browse all the conditions that are associated with Retinal detachment:

Retinal detachment (1,007 conditions)

Related publications that referenced our studies

Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .
Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on amitriptyline hydrochloride (the active ingredients of Amitriptyline hydrochloride) and Amitriptyline hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.